Accelerated approval scrutinized: confirmatory phase 4 studies on new drugs languish.
Mitka
Mike
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017327:Clinical Trials, Phase IV as Topic; D017277:Drug Approval; D000077156:Gefitinib; D011799:Quinazolines / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib